Bullish: Teledoc, NYSE: TDOC

The issue with Telemedicine is that it is not only contingent on the company and software itself but rather the doctors who use it. Paying attention to market news and doctor sentiments on the platform will be useful; the patient interfaces and user experience themselves will not be a significant differential factor.Telemedicine has a lot of competitors and it may also largely depend on hospital or corporate partnerships with software companies. Some leading competitors are Doxy.me, Doctor on Demand, and Virtuwell.

Healthline shows a more extensive list of competitors. Being a public company, this may set Teledoc up for some mergers with emerging startups dominating similar telehealth markets, or serve as competition once said startups may exit via merging or IPO.

Join our Discord: discord.gg/33FjvkPgyt

Join our Discussion: https://www.weclikd-beta.com/post/292689505520682